B1CTcu5 (Linear Brevinin CTcu5)
General Information
DRACP ID DRACP01974
Peptide Name B1CTcu5 (Linear Brevinin CTcu5)
Sequence LIAGLAANFLPQILCKIARKC
Sequence Length 21
UniProt ID E3SYG2 D2K8D1 C3RTH8
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane-targeted
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
A431 | Skin squamous cell carcinoma | Carcinoma | 50% Cytotoxicity>100 µg/ml | MTT assay | Not available | 1 |
Hemolytic Activity Human erythrocytes: 37% Hemolysis=200 µM
Normal (non-cancerous) Cytotoxicity HEK293: 50%Cytotoxicity>100 µg/ml; PBMC: 50%Cytotoxicity=75.1±1.46 µg/ml
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C103H178N28O24S2
Absent amino acids DEHMSTVWY
Common amino acids AL
Mass 261380
Pl 9.76
Basic residues 3
Acidic residues 0
Hydrophobic residues 12
Net charge 3
Boman Index 996
Hydrophobicity 106.67
Aliphatic Index 149.05
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 125
Absorbance 280nm 6.25
Polar residues 4
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 25997127
Title Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides
Doi 10.1371/journal.pone.0124210
Year 2015
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_13651